Safety of cefotaxime and other new beta-lactam antibiotics

Insights

Newer beta-lactam antibiotics like latamoxef and cefoperazone cause bleeding and disulfiram-like reactions due to their side chain. Cefotaxime, lacking this side chain, demonstrates a superior safety profile with minimal side effects, making it ideal for critically ill patients.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Beta-lactam antimicrobial agents have historically been considered safe and reliable.
  • Emerging concerns exist regarding newer beta-lactam drugs, specifically those with a methyltetrazolethiol side chain.
  • Latamoxef (moxalactam) and cefoperazone have been linked to coagulation abnormalities, bleeding, and disulfiram-like reactions.

Purpose of the Study:

  • To evaluate the safety profiles of newer beta-lactam antimicrobial agents.
  • To compare the adverse effects of cefotaxime against other beta-lactams with a methyltetrazolethiol side chain.
  • To inform clinical selection of antibiotics for seriously ill patients based on safety data.

Main Methods:

  • Review of clinical trial data and reported adverse events associated with beta-lactam antibiotics.
  • Comparative analysis of side effect profiles, focusing on coagulation abnormalities, bleeding, disulfiram-like reactions, and diarrhea.
  • Identification of specific structural components (methyltetrazolethiol side chain) linked to adverse events.

Main Results:

  • Latamoxef and cefoperazone, possessing the methyltetrazolethiol side chain, are associated with significant coagulation issues, bleeding, and disulfiram-like reactions.
  • Cefotaxime, which lacks the methyltetrazolethiol side chain, did not demonstrate these adverse effects.
  • Diarrhea, a common side effect of cefoperazone, occurred in only 1% of patients receiving cefotaxime, and was typically mild.

Conclusions:

  • The methyltetrazolethiol side chain in certain beta-lactam antibiotics is a key factor contributing to serious adverse events.
  • Cefotaxime exhibits a significantly better safety profile compared to latamoxef and cefoperazone.
  • Cefotaxime's safety record makes it a preferred choice for empirical antimicrobial therapy in critically ill patients.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...